Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer

We have demonstrated previously that melatonin attenuates hepatotoxicity triggered by high doses of (−)-epigallocatechin-3-gallate (EGCG) in mice. The current work investigated the influence of melatonin on the oncostatic activity of EGCG in two cancer cell lines, wherein melatonin induced an opposi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lingyun, He, Yufeng, Wu, Ximing, Zhao, Guangshan, Zhang, Ke, Yang, Chung S., Reiter, Russel J., Zhang, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678710/
https://www.ncbi.nlm.nih.gov/pubmed/31331008
http://dx.doi.org/10.3390/cells8070745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678710/
https://www.ncbi.nlm.nih.gov/pubmed/31331008
http://dx.doi.org/10.3390/cells8070745

Ejemplares similares